For immediate release 4 October 2024
CVS GROUP plc
("CVS", the "Company" or the "Group")
Long Term Incentive Plan Awards and PDMR Dealing
CVS, the UK listed veterinary group and a leading provider of veterinary services, announces that it has granted option awards over a total of 197,820 of the Company's ordinary shares of 0.2 pence each ("Ordinary Shares") under the CVS Group Long Term Incentive Plan 2024 ("LTIP 18") (the "Options"). Certain of the Options were awarded to the Directors named below, with the balance being issued to certain other employees.
Name Role Number of Options
Richard Fairman Chief Executive Officer 55,581
Robin Alfonso Chief Financial Officer 30,460
Paul Higgs Chief Veterinary Officer 26,144
The awards will vest in three years' time, subject to performance criteria being satisfied. These vesting criteria relate to the Company's earnings per share growth and total shareholder return over the three-year period between 1 July 2024 and 30 June 2027.
The notification below, made in accordance with the requirements of UK MAR, provides further detail.
CVS Group plc via Camarco
Richard Fairman, CEO
Scott Morrison, Company Secretary
Peel Hunt LLP (Nominated Adviser & Joint Broker) +44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark / Lalit Bose
Berenberg (Joint Broker) +44 (0)20 3207 7800
Toby Flaux / Ben Wright / James Thompson / Milo Bonser
Camarco (Financial PR)
Ginny Pulbrook +44 (0)7961 315 138
Geoffrey Pelham-Lane +44 (0)7733 124 226
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Richard Fairman | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Chief Executive Officer | ||||
| b) | Initial notification /Amendment | Initial Notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | CVS Group plc | ||||
| b) | LEI | 213800J41XDQ2NX48O05 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument
Identification code | Options over Ordinary shares of 0.2 pence each
GB00B2863827 | ||||
| b) | Nature of the transaction | Grant of Options under LTIP 18. | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information
- Aggregated volume
- Price |
N/A | ||||
| e) | Date of the transaction | 4 October 2024 | ||||
| f) | Place of the transaction | Off market | ||||
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Robin Alfonso | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Chief Financial Officer | ||||
| b) | Initial notification /Amendment | Initial Notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | CVS Group plc | ||||
| b) | LEI | 213800J41XDQ2NX48O05 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument
Identification code | Options over Ordinary shares of 0.2 pence each
GB00B2863827 | ||||
| b) | Nature of the transaction | Grant of Options under LTIP 18. | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information
- Aggregated volume
- Price |
N/A | ||||
| e) | Date of the transaction | 4 October 2024 | ||||
| f) | Place of the transaction | Off market | ||||
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Paul Higgs | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Chief Veterinary Officer | ||||
| b) | Initial notification /Amendment | Initial Notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | CVS Group plc | ||||
| b) | LEI | 213800J41XDQ2NX48O05 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument
Identification code | Options over Ordinary shares of 0.2 pence each
GB00B2863827 | ||||
| b) | Nature of the transaction | Grant of Options under LTIP 18. | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information
- Aggregated volume
- Price |
N/A | ||||
| e) | Date of the transaction | 4 October 2024 | ||||
| f) | Place of the transaction | Off market | ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
